ALT vs TWLO · rev $20.0K vs P/E 1087, rev $4.46B
Altimmune Inc (ALT) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
ALT currently screens at market cap $527.0M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the ALT and TWLO stock pages for the full models.
Not investment advice.